Clinical Trials Directory

Trials / Completed

CompletedNCT06502509

Kombucha Tea for Improving Defecation in Patients With Schizophrenia- a Randomized Controlled Study

How Does Kombucha Tea Improve Difficulty During Defecation in Patients With Schizophrenia- A Randomized, Double-blinded, Placebo-controlled, Parallel Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
TsaoTun Psychiatric Center, Department of Health, Taiwan · Academic / Other
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Patients with schizophrenia frequently have difficulties in bowel habits due to medical adverse effects and unhealthy lifestyle, and the use of various interventions to ameliorate the problems have been noted in clinical setting. Probiotics including Kombucha tea have been proved to modulate the human gut microbiota which may help to improve the stool passage, and have been attracting the public attention across the world. However, little is known among the patients with schizophrenia. In the present study, the research team intends to evaluate effectiveness of Kombucha tea when used in the clinical settings.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCommercial Kombucha tea (Brand name E-Ben Organic Kombucha Lemon)Commercial lemon kombucha tea (Brand:E-Ben Organic Kombucha Lemon), which will be given to participants in opaque bottles for 8 weeks.
DIETARY_SUPPLEMENTLemon teaDiluted lemon juice with the same pH as the commercial kombucha tea as placebo, which will be given to participants in opaque bottles for 8 weeks.

Timeline

Start date
2024-03-11
Primary completion
2024-06-03
Completion
2024-07-08
First posted
2024-07-16
Last updated
2024-07-16

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT06502509. Inclusion in this directory is not an endorsement.